US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 781.980
  • +3.910+0.50%
Close Jan 3 16:00 ET
  • 781.000
  • -0.980-0.13%
Post 20:01 ET
742.35BMarket Cap84.54P/E (TTM)

About Eli Lilly and Co Company

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Company Profile

SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com

Company Executives

  • Name
  • Position
  • Salary
  • David A. Ricks
  • Chairman of the Board, President and Chief Executive Officer
  • 26.57M
  • Lucas Montarce
  • Executive Vice President and Chief Financial Officer
  • --
  • Dr. Daniel M. Skovronsky, M.D.
  • Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
  • 11.85M
  • Diogo Rau
  • Executive Vice President, Chief Information Officer and Chief Digital Officer
  • --
  • Donald A. Zakrowski
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Alonzo Weems
  • Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
  • --
  • Anat Hakim
  • Executive Vice President, General Counsel and Secretary
  • 7.01M
  • Eric Dozier
  • Executive Vice President, Human Resources and Diversity
  • --
  • Anne E. White
  • Executive Vice President and President, Lilly Neuroscience
  • --
  • Patrik Jonsson
  • Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
  • --
  • Johna L. Norton
  • Executive Vice President, Global Quality
  • --
  • Edgardo Hernandez
  • Executive Vice President and President, Manufacturing Operations
  • --
  • Jacob S. Van Naarden
  • Executive Vice President and President, Loxo
  • 4.89M
  • Ilya Yuffa
  • Executive Vice President and President, Lilly International
  • --
  • Jamere Jackson
  • Independent Director
  • 345.00K
  • Jon R. Moeller
  • Independent Director
  • --
  • Gabrielle Sulzberger, J.D.,M.B.A.
  • Independent Director
  • 335.50K
  • Jon Erik Fyrwald
  • Independent Director
  • 344.88K
  • Dr. William G. Kaelin, Jr
  • Independent Director
  • 349.15K
  • Katherine Baicker
  • Independent Director
  • 336.00K
  • Ralph Alvarez
  • Independent Director
  • 336.00K
  • Dr. Mary Lynne Hedley,PhD
  • Independent Director
  • 319.00K
  • Juan R. Luciano
  • Lead Independent Director
  • 373.00K
  • Kimberly H. Johnson
  • Independent Director
  • 316.00K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DexCom
DXCM
+3.27%
Collegium Pharmaceutical
COLL
+3.07%
Lantheus
LNTH
+2.71%
Cars.com
CARS
+1.72%
YETI Holdings
YETI
+1.60%

Unlock the Full List

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday+0.38%